Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 172Cr | 20.6x | -0.26 | MYR 2.39 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Duopharma Biotech | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 118Cr | 21.4x | -2.34 | MYR 1.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Amway | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 113Cr | 9.1x | 0.6 | MYR 6.86 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
Kotra Industries | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 66.59Cr | 16.3x | -0.46 | MYR 4.49 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 47.56Cr | 5.1x | 0.04 | MYR 0.33 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
YSP Southeast Asia | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 32.34Cr | 11.3x | -0.63 | MYR 2.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhone Ma | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 14.71Cr | 16x | 1.89 | MYR 0.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
Bioalpha | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 8.44Cr | -1.9x | -0.11 | MYR 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |